{"name":"M.D. Anderson Cancer Center","slug":"m-d-anderson-cancer-center","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-03-01","label":"Femara Phase 3 readout (Metastatic Breast Cancer)","drug":"Femara","drugSlug":"femara","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-12-01","label":"Velban Phase 3 readout (Sarcoma,Soft Tissue)","drug":"Velban","drugSlug":"velban","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-01-01","label":"Velban Phase 3 readout (Langerhans Cell Histiocytosis)","drug":"Velban","drugSlug":"velban","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":33,"colorKey":"oncology","drugs":[{"name":"ABLC","genericName":"ABLC","slug":"ablc","indication":"Other","status":"marketed"},{"name":"Genasense","genericName":"Genasense","slug":"genasense","indication":"Other","status":"discontinued"},{"name":"Anvirzel","genericName":"Anvirzel","slug":"anvirzel","indication":"Other","status":"discontinued"},{"name":"Fentanyl Nasal Spray","genericName":"Fentanyl Nasal Spray","slug":"fentanyl-nasal-spray","indication":"Other","status":"marketed"},{"name":"P-Sam","genericName":"P-Sam","slug":"p-sam","indication":"Other","status":"phase_2"},{"name":"PCV20","genericName":"PCV20","slug":"pcv20","indication":"Other","status":"marketed"},{"name":"6-Thioguanine","genericName":"6-Thioguanine","slug":"6-thioguanine","indication":"Other","status":"marketed"},{"name":"Actonel (Risedronate)","genericName":"Actonel (Risedronate)","slug":"actonel-risedronate","indication":"Osteoporosis in postmenopausal women","status":"phase_3"},{"name":"Anti-GITR Agonistic Monoclonal Antibody BMS-986156","genericName":"Anti-GITR Agonistic Monoclonal Antibody BMS-986156","slug":"anti-gitr-agonistic-monoclonal-antibody-bms-986156","indication":"Other","status":"phase_1"},{"name":"Avandamet","genericName":"Avandamet","slug":"avandamet","indication":"Other","status":"marketed"},{"name":"Bioperine","genericName":"Bioperine","slug":"bioperine","indication":"Other","status":"marketed"},{"name":"Caphosol","genericName":"Caphosol","slug":"caphosol","indication":"Other","status":"discontinued"},{"name":"Carboplatin MTD","genericName":"Carboplatin MTD","slug":"carboplatin-mtd","indication":"Other","status":"phase_1"},{"name":"Chemotherapy for hematologic malignancy","genericName":"Chemotherapy for hematologic malignancy","slug":"chemotherapy-for-hematologic-malignancy","indication":"Other","status":"phase_1"},{"name":"Cigarette","genericName":"Cigarette","slug":"cigarette","indication":"Other","status":"phase_2"},{"name":"Cytrabine","genericName":"Cytrabine","slug":"cytrabine","indication":"Other","status":"phase_1"},{"name":"Edetate Calcium Disodium","genericName":"Edetate Calcium Disodium","slug":"edetate-calcium-disodium","indication":"Lead poisoning (acute and chronic lead toxicity)","status":"marketed"},{"name":"Haelan","genericName":"Haelan","slug":"haelan","indication":"Other","status":"discontinued"},{"name":"Hydromorphone PCA","genericName":"Hydromorphone PCA","slug":"hydromorphone-pca","indication":"Other","status":"marketed"},{"name":"Hyperpolarized 13-C-pyruvate","genericName":"Hyperpolarized 13-C-pyruvate","slug":"hyperpolarized-13-c-pyruvate","indication":"Other","status":"phase_1"},{"name":"Lisaftoclax","genericName":"Lisaftoclax","slug":"lisaftoclax","indication":"Other","status":"phase_2"},{"name":"Listaftoclax","genericName":"Listaftoclax","slug":"listaftoclax","indication":"Other","status":"phase_1"},{"name":"Luprolide","genericName":"Luprolide","slug":"luprolide","indication":"Other","status":"phase_2"},{"name":"Nadunolimab","genericName":"Nadunolimab","slug":"nadunolimab","indication":"Other","status":"phase_2"},{"name":"Novantrone","genericName":"Novantrone","slug":"novantrone","indication":"Other","status":"phase_3"},{"name":"Pepcid","genericName":"Pepcid","slug":"pepcid","indication":"Other","status":"marketed"},{"name":"Phenergan","genericName":"Phenergan","slug":"phenergan","indication":"Other","status":"discontinued"},{"name":"Rituximab for Patients with B-Cell Malignancies","genericName":"Rituximab for Patients with B-Cell Malignancies","slug":"rituximab-for-patients-with-b-cell-malignancies","indication":"Other","status":"phase_1"},{"name":"Teriparatide (Forteo)","genericName":"Teriparatide (Forteo)","slug":"teriparatide-forteo","indication":"Osteoporosis in postmenopausal women at high risk for fracture","status":"marketed"},{"name":"Thrombopoietin","genericName":"Thrombopoietin","slug":"thrombopoietin","indication":"Other","status":"phase_1"},{"name":"VUEWAY","genericName":"VUEWAY","slug":"vueway","indication":"Other","status":"marketed"},{"name":"Velban","genericName":"Velban","slug":"velban","indication":"Other","status":"discontinued"},{"name":"Vitamin Supplements","genericName":"Vitamin Supplements","slug":"vitamin-supplements","indication":"General health and wellness","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":28,"colorKey":"cardiovascular","drugs":[{"name":"Radiation Therapy","genericName":"Radiation Therapy","slug":"radiation-therapy","indication":"Solid tumors (broad indication across multiple cancer types)","status":"phase_3"},{"name":"Alpharadin","genericName":"Alpharadin","slug":"alpharadin","indication":"Malignant tumor of prostate","status":"phase_1"},{"name":"Antiandrogen Therapy","genericName":"Antiandrogen Therapy","slug":"antiandrogen-therapy","indication":"Metastatic castration-resistant prostate cancer","status":"phase_3"},{"name":"Ara-C","genericName":"Ara-C","slug":"ara-c","indication":"Acute myeloid leukemia (AML)","status":"marketed"},{"name":"Bleomycin Sulfate (BLM)","genericName":"Bleomycin Sulfate (BLM)","slug":"bleomycin-sulfate-blm","indication":"Hodgkin lymphoma","status":"phase_3"},{"name":"Calaspargase pegol-mknl","genericName":"Calaspargase pegol-mknl","slug":"calaspargase-pegol-mknl","indication":"Acute lymphoblastic leukemia (ALL), as part of combination chemotherapy","status":"phase_3"},{"name":"Cladribine (CLAD)","genericName":"Cladribine (CLAD)","slug":"cladribine-clad","indication":"Hairy cell leukemia","status":"marketed"},{"name":"Dacarbazine (DTIC)","genericName":"Dacarbazine (DTIC)","slug":"dacarbazine-dtic","indication":"Metastatic melanoma","status":"phase_3"},{"name":"Erwinase","genericName":"Erwinase","slug":"erwinase","indication":"Acute lymphoid leukemia","status":"marketed"},{"name":"Femara","genericName":"Femara","slug":"femara","indication":"Controlled ovarian stimulation","status":"discontinued"},{"name":"Fentanyl Buccal Tablet","genericName":"Fentanyl Buccal Tablet","slug":"fentanyl-buccal-tablet","indication":"Breakthrough cancer pain in opioid-tolerant patients","status":"phase_3"},{"name":"Filgrastim SD/01","genericName":"Filgrastim SD/01","slug":"filgrastim-sd-01","indication":"Chemotherapy-induced neutropenia in cancer patients","status":"phase_3"},{"name":"Fluorouracil/Calcipotriene","genericName":"Fluorouracil/Calcipotriene","slug":"fluorouracil-calcipotriene","indication":"Actinic keratosis","status":"phase_3"},{"name":"G-CSF (Filgrastim)","genericName":"G-CSF (Filgrastim)","slug":"g-csf-filgrastim","indication":"Chemotherapy-induced neutropenia in cancer patients","status":"phase_3"},{"name":"GSK2118436","genericName":"GSK2118436","slug":"gsk2118436","indication":"Metastatic melanoma with BRAF V600E mutation","status":"phase_3"},{"name":"Gleevec","genericName":"Gleevec","slug":"gleevec","indication":"Blastic phase chronic myeloid leukemia","status":"marketed"},{"name":"High Dose Melphalan","genericName":"High Dose Melphalan","slug":"high-dose-melphalan","indication":"Multiple myeloma (with autologous stem cell transplantation)","status":"phase_3"},{"name":"I-131 Iodocholesterol","genericName":"I-131 Iodocholesterol","slug":"i-131-iodocholesterol","indication":"Adrenocortical carcinoma (diagnostic and therapeutic)","status":"phase_3"},{"name":"Ibritumomab Tiuxetan (Zevalin)","genericName":"Ibritumomab Tiuxetan (Zevalin)","slug":"ibritumomab-tiuxetan-zevalin","indication":"Relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin lymphoma","status":"marketed"},{"name":"Imatinib mesylate (STI571)","genericName":"Imatinib mesylate (STI571)","slug":"imatinib-mesylate-sti571","indication":"Chronic myeloid leukemia (CML), Philadelphia chromosome positive","status":"phase_3"},{"name":"Methoxsalen+ECP","genericName":"Methoxsalen+ECP","slug":"methoxsalen-ecp","indication":"Cutaneous T-cell lymphoma (mycosis fungoides)","status":"marketed"},{"name":"Paclitaxel (Taxol)","genericName":"Paclitaxel (Taxol)","slug":"paclitaxel-taxol","indication":"Metastatic carcinoma of the ovary","status":"phase_3"},{"name":"Pegylated liposomal doxorubicin hydrochloride","genericName":"Pegylated liposomal doxorubicin hydrochloride","slug":"pegylated-liposomal-doxorubicin-hydrochloride","indication":"Metastatic ovarian cancer","status":"marketed"},{"name":"Proflavine Hemisulfate","genericName":"Proflavine Hemisulfate","slug":"proflavine-hemisulfate","indication":"Topical antiseptic and antimicrobial agent (historical use)","status":"marketed"},{"name":"Revlimid","genericName":"Revlimid","slug":"revlimid","indication":"Follicular lymphoma","status":"marketed"},{"name":"Tarceva","genericName":"Tarceva","slug":"tarceva","indication":"Adenocarcinoma of pancreas","status":"marketed"},{"name":"Taxol","genericName":"Taxol","slug":"taxol","indication":"Carcinoma of breast","status":"marketed"},{"name":"Vitamin C (Ascorbic Acid)","genericName":"Vitamin C (Ascorbic Acid)","slug":"vitamin-c-ascorbic-acid","indication":"Adjunctive therapy in cancer treatment (investigational)","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"neuroscience","drugs":[{"name":"Dalteparin (Fragmin)","genericName":"Dalteparin (Fragmin)","slug":"dalteparin-fragmin","indication":"Thromboprophylaxis in patients undergoing abdominal surgery","status":"marketed"},{"name":"Nesiritide (Natrecor)","genericName":"Nesiritide (Natrecor)","slug":"nesiritide-natrecor","indication":"Acute decompensated heart failure with dyspnea at rest or with minimal exertion","status":"marketed"},{"name":"Tc99m sestamibi","genericName":"Tc99m sestamibi","slug":"tc99m-sestamibi","indication":"Myocardial perfusion imaging for detection of coronary artery disease","status":"marketed"},{"name":"Zinecard","genericName":"Zinecard","slug":"zinecard","indication":"Doxorubicin Induced Cardiomyopathy","status":"phase_1"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Filgrastim-sndz","genericName":"Filgrastim-sndz","slug":"filgrastim-sndz","indication":"Chemotherapy-induced neutropenia (CIN) in patients with non-myeloid malignancies","status":"marketed"},{"name":"Lapine T-Lymphocyte Immune Globulin","genericName":"Lapine T-Lymphocyte Immune Globulin","slug":"lapine-t-lymphocyte-immune-globulin","indication":"Prevention of acute rejection in organ transplantation","status":"phase_3"},{"name":"Thymoglobulin (ATG)","genericName":"Thymoglobulin (ATG)","slug":"thymoglobulin-atg","indication":"Acute rejection in renal transplant recipients","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"I-131 Metaiodobenzylguanidine","genericName":"I-131 Metaiodobenzylguanidine","slug":"i-131-metaiodobenzylguanidine","indication":"Relapsed or refractory high-risk neuroblastoma","status":"phase_3"},{"name":"Qutenza Patch","genericName":"Qutenza Patch","slug":"qutenza-patch","indication":"Postherpetic neuralgia (PHN)","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Vioxx","genericName":"Vioxx","slug":"vioxx","indication":"Dysmenorrhea","status":"discontinued"}]}],"pipeline":[{"name":"ABLC","genericName":"ABLC","slug":"ablc","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Genasense","genericName":"Genasense","slug":"genasense","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Anvirzel","genericName":"Anvirzel","slug":"anvirzel","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fentanyl Nasal Spray","genericName":"Fentanyl Nasal Spray","slug":"fentanyl-nasal-spray","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Filgrastim-sndz","genericName":"Filgrastim-sndz","slug":"filgrastim-sndz","phase":"marketed","mechanism":"Filgrastim-sndz is a granulocyte colony-stimulating factor (G-CSF) analog that stimulates the proliferation and differentiation of neutrophil progenitor cells in bone marrow.","indications":["Chemotherapy-induced neutropenia (CIN) in patients with non-myeloid malignancies","Severe chronic neutropenia","Mobilization of peripheral blood progenitor cells for autologous transplantation"],"catalyst":""},{"name":"P-Sam","genericName":"P-Sam","slug":"p-sam","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"PCV20","genericName":"PCV20","slug":"pcv20","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Radiation Therapy","genericName":"Radiation Therapy","slug":"radiation-therapy","phase":"phase_3","mechanism":"Radiation therapy uses high-energy ionizing radiation to damage cancer cell DNA and trigger cell death.","indications":["Solid tumors (broad indication across multiple cancer types)","Localized and metastatic cancers as primary or adjuvant treatment"],"catalyst":""},{"name":"6-Thioguanine","genericName":"6-Thioguanine","slug":"6-thioguanine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Actonel (Risedronate)","genericName":"Actonel (Risedronate)","slug":"actonel-risedronate","phase":"phase_3","mechanism":"Risedronate inhibits bone resorption by binding to hydroxyapatite on bone surfaces and inhibiting osteoclast activity.","indications":["Osteoporosis in postmenopausal women","Paget's disease of bone","Glucocorticoid-induced osteoporosis","Bone metastases (supportive care)"],"catalyst":""},{"name":"Alpharadin","genericName":"Alpharadin","slug":"alpharadin","phase":"phase_1","mechanism":"Small molecule","indications":["Malignant tumor of prostate"],"catalyst":""},{"name":"Anti-GITR Agonistic Monoclonal Antibody BMS-986156","genericName":"Anti-GITR Agonistic Monoclonal Antibody BMS-986156","slug":"anti-gitr-agonistic-monoclonal-antibody-bms-986156","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Antiandrogen Therapy","genericName":"Antiandrogen Therapy","slug":"antiandrogen-therapy","phase":"phase_3","mechanism":"Antiandrogen therapy blocks the effects of androgens (male hormones) by inhibiting androgen receptor signaling, thereby slowing or stopping the growth of androgen-dependent cancer cells.","indications":["Metastatic castration-resistant prostate cancer","Hormone-sensitive prostate cancer"],"catalyst":""},{"name":"Ara-C","genericName":"Ara-C","slug":"ara-c","phase":"marketed","mechanism":"Ara-C is a cytidine analog that inhibits DNA synthesis by being incorporated into DNA and blocking cell division, primarily affecting rapidly dividing cancer cells.","indications":["Acute myeloid leukemia (AML)","Acute lymphoblastic leukemia (ALL)","Chronic myeloid leukemia (CML) in blast crisis","Lymphoma"],"catalyst":""},{"name":"Avandamet","genericName":"Avandamet","slug":"avandamet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bioperine","genericName":"Bioperine","slug":"bioperine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bleomycin Sulfate (BLM)","genericName":"Bleomycin Sulfate (BLM)","slug":"bleomycin-sulfate-blm","phase":"phase_3","mechanism":"Bleomycin is a chemotherapeutic antibiotic that binds to DNA and causes strand breaks, leading to cell death.","indications":["Hodgkin lymphoma","Non-Hodgkin lymphoma","Testicular cancer","Squamous cell carcinoma of the head and neck","Cervical cancer"],"catalyst":""},{"name":"Calaspargase pegol-mknl","genericName":"Calaspargase pegol-mknl","slug":"calaspargase-pegol-mknl","phase":"phase_3","mechanism":"Calaspargase pegol-mknl is a pegylated asparaginase that depletes asparagine, an amino acid required for leukemic cell survival and proliferation.","indications":["Acute lymphoblastic leukemia (ALL), as part of combination chemotherapy"],"catalyst":""},{"name":"Caphosol","genericName":"Caphosol","slug":"caphosol","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Carboplatin MTD","genericName":"Carboplatin MTD","slug":"carboplatin-mtd","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Chemotherapy for hematologic malignancy","genericName":"Chemotherapy for hematologic malignancy","slug":"chemotherapy-for-hematologic-malignancy","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cigarette","genericName":"Cigarette","slug":"cigarette","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cladribine (CLAD)","genericName":"Cladribine (CLAD)","slug":"cladribine-clad","phase":"marketed","mechanism":"Cladribine is a purine nucleoside analog that is phosphorylated intracellularly and incorporated into DNA, causing strand breaks and apoptosis in lymphoid cells.","indications":["Hairy cell leukemia","Chronic lymphocytic leukemia","Multiple sclerosis (relapsing-remitting)"],"catalyst":""},{"name":"Cytrabine","genericName":"Cytrabine","slug":"cytrabine","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dacarbazine (DTIC)","genericName":"Dacarbazine (DTIC)","slug":"dacarbazine-dtic","phase":"phase_3","mechanism":"Dacarbazine is an alkylating agent that cross-links DNA, preventing cell division and causing cancer cell death.","indications":["Metastatic melanoma","Hodgkin lymphoma","Soft tissue sarcoma"],"catalyst":""},{"name":"Dalteparin (Fragmin)","genericName":"Dalteparin (Fragmin)","slug":"dalteparin-fragmin","phase":"marketed","mechanism":"Dalteparin is a low-molecular-weight heparin that inhibits blood coagulation by enhancing the activity of antithrombin III against factor Xa and thrombin.","indications":["Thromboprophylaxis in patients undergoing abdominal surgery","Thromboprophylaxis in patients with restricted mobility during acute illness","Treatment of acute deep vein thrombosis","Treatment of pulmonary embolism","Unstable angina and non-ST-segment elevation myocardial infarction"],"catalyst":""},{"name":"Edetate Calcium Disodium","genericName":"Edetate Calcium Disodium","slug":"edetate-calcium-disodium","phase":"marketed","mechanism":"Edetate calcium disodium is a chelating agent that binds and removes heavy metals (particularly lead) from the body by forming stable complexes that are excreted in urine.","indications":["Lead poisoning (acute and chronic lead toxicity)","Heavy metal poisoning"],"catalyst":""},{"name":"Erwinase","genericName":"Erwinase","slug":"erwinase","phase":"marketed","mechanism":"Small molecule","indications":["Acute lymphoid leukemia"],"catalyst":""},{"name":"Femara","genericName":"Femara","slug":"femara","phase":"discontinued","mechanism":"Cytochrome P450 11B2, mitochondrial, Aromatase, Cytochrome P450 11B1, mitochondrial","indications":["Controlled ovarian stimulation","Early Breast Cancer Hormone Receptor Positive and Postmenopausal","Hormone receptor positive malignant neoplasm of breast","Induction of ovulation in polycystic ovarian syndrome","Induction of ovulation in unexplained infertility"],"catalyst":""},{"name":"Fentanyl Buccal Tablet","genericName":"Fentanyl Buccal Tablet","slug":"fentanyl-buccal-tablet","phase":"phase_3","mechanism":"Fentanyl buccal tablet delivers the opioid fentanyl through the buccal mucosa to provide rapid analgesia by binding to mu opioid receptors in the central nervous system.","indications":["Breakthrough cancer pain in opioid-tolerant patients"],"catalyst":""},{"name":"Filgrastim SD/01","genericName":"Filgrastim SD/01","slug":"filgrastim-sd-01","phase":"phase_3","mechanism":"Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that stimulates the production and release of neutrophils from bone marrow to increase white blood cell counts.","indications":["Chemotherapy-induced neutropenia in cancer patients","Mobilization of peripheral blood progenitor cells for stem cell transplantation"],"catalyst":""},{"name":"Fluorouracil/Calcipotriene","genericName":"Fluorouracil/Calcipotriene","slug":"fluorouracil-calcipotriene","phase":"phase_3","mechanism":"Fluorouracil inhibits thymidylate synthase to disrupt DNA synthesis, while calcipotriene promotes keratinocyte differentiation and immune modulation for topical anticancer effect.","indications":["Actinic keratosis","Non-melanoma skin cancer (investigational)"],"catalyst":""},{"name":"G-CSF (Filgrastim)","genericName":"G-CSF (Filgrastim)","slug":"g-csf-filgrastim","phase":"phase_3","mechanism":"Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that stimulates the bone marrow to produce and release neutrophils into the bloodstream.","indications":["Chemotherapy-induced neutropenia in cancer patients","Severe chronic neutropenia","Mobilization of peripheral blood progenitor cells for autologous transplantation"],"catalyst":""},{"name":"GSK2118436","genericName":"GSK2118436","slug":"gsk2118436","phase":"phase_3","mechanism":"GSK2118436 is a BRAF V600E inhibitor that blocks mutant BRAF kinase signaling in melanoma cells.","indications":["Metastatic melanoma with BRAF V600E mutation","Unresectable melanoma with BRAF V600E mutation"],"catalyst":""},{"name":"Gleevec","genericName":"Gleevec","slug":"gleevec","phase":"marketed","mechanism":"Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, ATP-binding cassette sub-family G member 2, ATP-dependent RNA helicase DDX3X","indications":["Blastic phase chronic myeloid leukemia","Chronic Myelocytic Leukemia Accelerated Phase","Chronic eosinophilic leukemia","Chronic phase chronic myeloid leukemia","Dermatofibrosarcoma protuberans"],"catalyst":""},{"name":"Haelan","genericName":"Haelan","slug":"haelan","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"High Dose Melphalan","genericName":"High Dose Melphalan","slug":"high-dose-melphalan","phase":"phase_3","mechanism":"High-dose melphalan is an alkylating agent that crosslinks DNA strands, causing cell death, and is used in high doses followed by stem cell rescue to treat hematologic malignancies.","indications":["Multiple myeloma (with autologous stem cell transplantation)","Light chain amyloidosis","Waldenström macroglobulinemia"],"catalyst":""},{"name":"Hydromorphone PCA","genericName":"Hydromorphone PCA","slug":"hydromorphone-pca","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hyperpolarized 13-C-pyruvate","genericName":"Hyperpolarized 13-C-pyruvate","slug":"hyperpolarized-13-c-pyruvate","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"I-131 Iodocholesterol","genericName":"I-131 Iodocholesterol","slug":"i-131-iodocholesterol","phase":"phase_3","mechanism":"I-131 Iodocholesterol is a radiolabeled cholesterol analog that localizes to adrenocortical tissue and delivers targeted radiation for imaging and therapeutic purposes in adrenocortical carcinoma.","indications":["Adrenocortical carcinoma (diagnostic and therapeutic)"],"catalyst":""},{"name":"I-131 Metaiodobenzylguanidine","genericName":"I-131 Metaiodobenzylguanidine","slug":"i-131-metaiodobenzylguanidine","phase":"phase_3","mechanism":"I-131 MIBG is a radioactive iodine-labeled compound that selectively accumulates in neuroendocrine tumors and delivers targeted radiation therapy to kill cancer cells.","indications":["Relapsed or refractory high-risk neuroblastoma","Metastatic pheochromocytoma and paraganglioma"],"catalyst":""},{"name":"Ibritumomab Tiuxetan (Zevalin)","genericName":"Ibritumomab Tiuxetan (Zevalin)","slug":"ibritumomab-tiuxetan-zevalin","phase":"marketed","mechanism":"Ibritumomab tiuxetan is a radiolabeled monoclonal antibody that binds to CD20 on B cells and delivers yttrium-90 radiation directly to tumor cells.","indications":["Relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin lymphoma","Previously untreated follicular lymphoma (in combination with rituximab)"],"catalyst":""},{"name":"Imatinib mesylate (STI571)","genericName":"Imatinib mesylate (STI571)","slug":"imatinib-mesylate-sti571","phase":"phase_3","mechanism":"Imatinib is a tyrosine kinase inhibitor that blocks the BCR-ABL fusion protein and other kinases, preventing abnormal cell proliferation in chronic myeloid leukemia and other cancers.","indications":["Chronic myeloid leukemia (CML), Philadelphia chromosome positive","Gastrointestinal stromal tumors (GIST)","Acute lymphoblastic leukemia (ALL), Philadelphia chromosome positive"],"catalyst":""},{"name":"Lapine T-Lymphocyte Immune Globulin","genericName":"Lapine T-Lymphocyte Immune Globulin","slug":"lapine-t-lymphocyte-immune-globulin","phase":"phase_3","mechanism":"Lapine T-lymphocyte immune globulin depletes T lymphocytes to suppress immune rejection and graft-versus-host disease.","indications":["Prevention of acute rejection in organ transplantation","Treatment of severe aplastic anemia","Prevention and treatment of graft-versus-host disease"],"catalyst":""},{"name":"Lisaftoclax","genericName":"Lisaftoclax","slug":"lisaftoclax","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Listaftoclax","genericName":"Listaftoclax","slug":"listaftoclax","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Luprolide","genericName":"Luprolide","slug":"luprolide","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Methoxsalen+ECP","genericName":"Methoxsalen+ECP","slug":"methoxsalen-ecp","phase":"marketed","mechanism":"Methoxsalen combined with extracorporeal photochemotherapy (ECP) uses a photosensitizing agent activated by ultraviolet A light to induce apoptosis in circulating malignant T cells.","indications":["Cutaneous T-cell lymphoma (mycosis fungoides)","Sézary syndrome"],"catalyst":""},{"name":"Nadunolimab","genericName":"Nadunolimab","slug":"nadunolimab","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nesiritide (Natrecor)","genericName":"Nesiritide (Natrecor)","slug":"nesiritide-natrecor","phase":"marketed","mechanism":"Nesiritide is a recombinant B-type natriuretic peptide that binds to natriuretic peptide receptors, promoting vasodilation and sodium excretion to reduce cardiac preload and afterload.","indications":["Acute decompensated heart failure with dyspnea at rest or with minimal exertion"],"catalyst":""},{"name":"Novantrone","genericName":"Novantrone","slug":"novantrone","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paclitaxel (Taxol)","genericName":"Paclitaxel (Taxol)","slug":"paclitaxel-taxol","phase":"phase_3","mechanism":"Paclitaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis in cancer cells.","indications":["Metastatic carcinoma of the ovary","Breast cancer (metastatic and adjuvant)","Non-small cell lung cancer","Kaposi's sarcoma","Gastric adenocarcinoma"],"catalyst":""},{"name":"Pegylated liposomal doxorubicin hydrochloride","genericName":"Pegylated liposomal doxorubicin hydrochloride","slug":"pegylated-liposomal-doxorubicin-hydrochloride","phase":"marketed","mechanism":"Pegylated liposomal doxorubicin delivers the chemotherapy agent doxorubicin encapsulated in liposomes coated with polyethylene glycol, which intercalates into DNA and inhibits topoisomerase II while reducing cardiotoxicity through prolonged circulation and selective tumor accumulation.","indications":["Metastatic ovarian cancer","AIDS-related Kaposi sarcoma","Multiple myeloma (in combination with bortezomib)","Breast cancer"],"catalyst":""},{"name":"Pepcid","genericName":"Pepcid","slug":"pepcid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Phenergan","genericName":"Phenergan","slug":"phenergan","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Proflavine Hemisulfate","genericName":"Proflavine Hemisulfate","slug":"proflavine-hemisulfate","phase":"marketed","mechanism":"Proflavine hemisulfate is an acridine dye that intercalates into DNA and generates reactive oxygen species, causing direct antimicrobial and antiproliferative effects.","indications":["Topical antiseptic and antimicrobial agent (historical use)","Investigational anticancer agent (limited clinical development)"],"catalyst":""},{"name":"Qutenza Patch","genericName":"Qutenza Patch","slug":"qutenza-patch","phase":"marketed","mechanism":"Qutenza is a topical capsaicin patch that desensitizes nociceptors (pain-sensing nerve fibers) by depleting substance P, reducing localized neuropathic pain.","indications":["Postherpetic neuralgia (PHN)","Peripheral neuropathic pain"],"catalyst":""},{"name":"Revlimid","genericName":"Revlimid","slug":"revlimid","phase":"marketed","mechanism":"Bromodomain-containing protein 4, Protein cereblon, Tumor necrosis factor","indications":["Follicular lymphoma","Mantle cell lymphoma","Marginal zone lymphoma","Multiple myeloma","Myelodysplastic syndrome"],"catalyst":""},{"name":"Rituximab for Patients with B-Cell Malignancies","genericName":"Rituximab for Patients with B-Cell Malignancies","slug":"rituximab-for-patients-with-b-cell-malignancies","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tarceva","genericName":"Tarceva","slug":"tarceva","phase":"marketed","mechanism":"AarF domain-containing protein kinase 4, Acyl-CoA dehydrogenase family member 11, Chaperone activity of bc1 complex-like, mitochondrial","indications":["Adenocarcinoma of pancreas","Non-small cell lung cancer"],"catalyst":""},{"name":"Taxol","genericName":"Taxol","slug":"taxol","phase":"marketed","mechanism":"Multidrug resistance-associated protein 7, Bile salt export pump, Melanocortin receptor 5","indications":["Carcinoma of breast","Carcinoma of fallopian tube","Hypertensive disorder","Kaposi's sarcoma","Malignant tumor of cervix"],"catalyst":""},{"name":"Tc99m sestamibi","genericName":"Tc99m sestamibi","slug":"tc99m-sestamibi","phase":"marketed","mechanism":"Tc-99m sestamibi is a radiotracer that accumulates in mitochondria of viable cells, allowing visualization of myocardial perfusion and detection of ischemia via nuclear imaging.","indications":["Myocardial perfusion imaging for detection of coronary artery disease","Assessment of myocardial viability","Evaluation of left ventricular function"],"catalyst":""},{"name":"Teriparatide (Forteo)","genericName":"Teriparatide (Forteo)","slug":"teriparatide-forteo","phase":"marketed","mechanism":"Teriparatide is a recombinant parathyroid hormone analog that stimulates osteoblasts to increase bone formation and remodeling.","indications":["Osteoporosis in postmenopausal women at high risk for fracture","Osteoporosis in men at high risk for fracture","Glucocorticoid-induced osteoporosis"],"catalyst":""},{"name":"Thrombopoietin","genericName":"Thrombopoietin","slug":"thrombopoietin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Thymoglobulin (ATG)","genericName":"Thymoglobulin (ATG)","slug":"thymoglobulin-atg","phase":"marketed","mechanism":"Thymoglobulin is a polyclonal antithymocyte globulin that depletes T lymphocytes by binding to multiple T-cell antigens and triggering their destruction.","indications":["Acute rejection in renal transplant recipients","Aplastic anemia (severe)","Graft-versus-host disease (GVHD) prophylaxis in hematopoietic stem cell transplantation"],"catalyst":""},{"name":"VUEWAY","genericName":"VUEWAY","slug":"vueway","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Velban","genericName":"Velban","slug":"velban","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vioxx","genericName":"Vioxx","slug":"vioxx","phase":"discontinued","mechanism":"Cytochrome c oxidase subunit 2, Prostaglandin E2 receptor EP2 subtype, Prostaglandin G/H synthase 1","indications":["Dysmenorrhea","Juvenile rheumatoid arthritis","Migraine","Osteoarthritis","Pain"],"catalyst":""},{"name":"Vitamin C (Ascorbic Acid)","genericName":"Vitamin C (Ascorbic Acid)","slug":"vitamin-c-ascorbic-acid","phase":"marketed","mechanism":"Vitamin C acts as an antioxidant and cofactor for enzymatic reactions, and at high doses may generate reactive oxygen species to selectively target cancer cells.","indications":["Adjunctive therapy in cancer treatment (investigational)","General nutritional supplementation"],"catalyst":""},{"name":"Vitamin Supplements","genericName":"Vitamin Supplements","slug":"vitamin-supplements","phase":"phase_3","mechanism":"Vitamin supplements provide essential nutrients to support various bodily functions.","indications":["General health and wellness"],"catalyst":""},{"name":"Zinecard","genericName":"Zinecard","slug":"zinecard","phase":"phase_1","mechanism":"DNA topoisomerase 2-beta, DNA topoisomerase 2-alpha","indications":["Doxorubicin Induced Cardiomyopathy","Extravasation Injury from Anthracycline Injection","Prevention of CMV Disease After Organ Transplant"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE51c1hmeE1HM01rd3R4ZjVvNndPUUhvclJaVlBuMDd5V1hRVXVFTWJBRkIyZ3JrcjhjMnQydVAxQkFyR2d5bjdMMmxHeUlleVduMkM3a3JOeDZBUVFnNEZJTS16dmozYzQyOWc?oc=5","date":"2026-02-18","type":"pipeline","source":"CTech","summary":"Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments - CTech","headline":"Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxOZFpfclhnRndBaWlHZEJLYjRuelJNMnk4TzE2bTAtWlJNY3VRZHEzbjNDblJfTXFhYjEtN1F5ZlpiQmRadjlPc3drSlp2bHI4RlRPWnNaU0U1NUJDanlpOVZvY1ZPODVpeEVyMnJfbDhlOGRWMHlUQ1NFZ0FfS2E5TlBSSV9waTBsalp1NGEyd0NRbDFzWFFTaW5rVGxJRmliOGRrTE5OX0U4andTUUxOMG9LOWFLVTJmVHdENFZoRUhsbjZzZVJJNDg2RlVvdXJISG5TT0FUYml4amlXT05UanBGVG0ydTFpMXZpNklKMnA2YTJxR2steHBMR0tTaDRZNE9iZzZTR2RnUnFSQW5NT0lvNm16NmJVSlp5QmkwTjdIR3lIT052OG5B?oc=5","date":"2026-02-18","type":"deal","source":"Morningstar","summary":"Starget Pharma Closes $18M Series A Financing and Announces Strategic Collaboration with Center for Molecular Imaging and Therapy in Louisiana - Morningstar","headline":"Starget Pharma Closes $18M Series A Financing and Announces Strategic Collaboration with Center for Molecular Imaging an","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNUUMwTG03aUxvd3dCNzg0OTE5Wkc5cm9SVVVDaEtrYnhtVWM0Q3pveW8ybGlURjBxc3Q2cG9qR1c4RXhTLWhkYmpwaFdRVFp0UFdmWmtraFRKLXpSZXBzeTlRME1KVXdqblZ3TFBrWXhPSGtOUS1QYlNTWUV6OFZObDB2YmhYYWppYzU3U0JXa3VmcWRMY2NtQUl6SXZCN2pSRXU0bFdqUzRzUDhiNm5zVEMtR2Y3NlIwUWJlNGFEZy1sZDJWbzRQTURDN0dPdFNvYVdhMUJYT19jMHd4STN6ZnJxSWtGQWpZYkVrOV9sTzRsNUR0SHc?oc=5","date":"2026-02-18","type":"deal","source":"KTBS 3","summary":"Starget Pharma secures $18M, launches cancer therapy collaboration in Shreveport - KTBS 3","headline":"Starget Pharma secures $18M, launches cancer therapy collaboration in Shreveport - KTBS 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"nature.com","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - nature.com","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNWF85UDltaWJHY0FXMDRMNGV1ZWgtTVltTWtrSldma1hjMVlTZjBPemtrRERzZFBrZ0xyNlR0QzVLUTh2WTNyemhOUlU3RTU0eEdJSnVvMzQ4bVFuR0VxcnJQVWV3SkliS3p5X3pqWHlTOS10czkxaExZN0lVX19iU0dOb3dnYUxBVFFfQnpHd00?oc=5","date":"2025-10-09","type":"pipeline","source":"University of Houston","summary":"Faculty News | College of Pharmacy - University of Houston","headline":"Faculty News | College of Pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQdWZTYWp6UGRyMXoyWlVZaWZ3VmptWkxkZUVaOEtmTExNM2phRWpWUl9NMXN6OWVDbnc2bDFrOEhoek5qNzZBUHc5cDVmRkZTNTlmbHJNbXNPeEhhaGZJSm9vdkMyZzEzTDd0aHhSeE43RmdWWlhWaTVYZzBCT1J5U1lvaHNvQ3JuWk01UjhUVHVTRlY3U3N1Q1NYcWZXRENUVXhPYzZsd1hrSjVUYThqNFZqLWRwOVh4V1RudmxFRVB6RTBZVlk1NnlIR0dGb0FCaGo3em1DdUJlaVJ6QjI3Qi1Mc1FlRXdWN1hBRGx3STM0UUIyMG9WUDRxVlBNZw?oc=5","date":"2025-09-05","type":"pipeline","source":"UT MD Anderson","summary":"MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies - UT MD Anderson","headline":"MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQei04V3FJb1NER210VTdURmw5YU1qQUdrOGE5LUtVX3BMR1hhaFpmaTBZMDBVUkxueUZTVkQzQXRKRmI2bzUwcGpXZ25LU091UTN6VFlYejM0VnVIclpIUXltVWJCM1pVZDRGZHlQLS1CdlViNmtsbE9FdTFSeFIzdjJNZGhmZUxYVnRBWldLMDdwbmpIRkZjU1JWRQ?oc=5","date":"2025-06-10","type":"pipeline","source":"Fierce Biotech","summary":"Quest Diagnostics taps MD Anderson for cancer risk blood test - Fierce Biotech","headline":"Quest Diagnostics taps MD Anderson for cancer risk blood test","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPZHhvb2hxRmhKTmEwT0lqVjVpQUZ4a0NpS1Nvb1RRTnZvRno1T1EwRHFTRFdIbGwtV0pHZ0ZBaGluZTlma1RSZ241WHB2VUhINGw5bzVVUm9FSWI5Y0p6SVo1cHg3cS1PblV5Zks5T2ZoUmZCNFlFRGdlcHdyU3dmOWNsTTdRV3llNDk1eFRPeGxaci1uMDhwTUx30gGfAUFVX3lxTE5xWkFsekFmaFIwZkVsMU9iNTUxYld4TmVQWmlUUHlEU1lFdl9hbW5PZm5QWWE4M2RzSDMxZkFWc2hESDhpbDRXWS1oRFRZZnpiVWZHX2JLenFYdWNIZFZXUHdJM0RWR0Q3ZHhWNE1FR1VOblQ0cDhRTDU1VnFHeXZYVnc3Y2lRMmxBVjJpamIxZklqN01vVDFrb1dvbVhEWQ?oc=5","date":"2024-04-26","type":"deal","source":"ABC7 Chicago","summary":"Rush, MD Anderson Cancer Center announce new partnership for Rush University, Rush Copley - ABC7 Chicago","headline":"Rush, MD Anderson Cancer Center announce new partnership for Rush University, Rush Copley - ABC7 Chicago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOTnlidHB5WXRvTUNRbTI4NXlTNkIxMXo1U1FLaERXLVdueWRxU2ZESzFkYXZyOVJzY1ZFNW8xV0NwY1RGZW9OZk9GSHRIeHZxbWlhLWhWNWpnZFFCVWN1Z2c3RUZvWnMwSVhrd0lNaGt0bkJrbkFNTW9aSU1JUnowckkwemd4eUxlVHlEVlNlVU1EQVFkTkYxM1dhYld3c2pjTktXLXhNdkpXMFRUQmxvcXM3bUJvbm1YQ0E5UC1xSWFON3RMYmFfc2JIOVFqNktEcGJsYTQzVW1CWU9Fekl3Q0dlQkVKQ1NnNDBDaTRUZS15c3NZTEVDUg?oc=5","date":"2023-11-07","type":"trial","source":"UT MD Anderson","summary":"MD Anderson and Jazz Pharmaceuticals announce five-year collaboration to evaluate zanidatamab in HER2-expressing cancers - UT MD Anderson","headline":"MD Anderson and Jazz Pharmaceuticals announce five-year collaboration to evaluate zanidatamab in HER2-expressing cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQdWQ4UFhTbzUybG00X0Y5V0YySm4xTlBHZGtyS1pRNHRjYWdaUHRzN0VteFNEaGF4OFRkSE1SXzZ2MTRnN1hkSE9kTGx4UlV0aE0weHpiUHhMaXZ0ellpQ2VQY0lQQl9YWGhzdkZmcXB3dzZpNnVTT0JMT2lIUzEwXzRXVW9pOW5HcExTM25ERmxqZlprNEJLVndTMm44V1JOeUZZZVNwX3RoV2szSmY2MGRDeVU?oc=5","date":"2021-04-14","type":"deal","source":"Boehringer Ingelheim","summary":"expanded-collaboration-MD-Anderson - Boehringer Ingelheim","headline":"expanded-collaboration-MD-Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPa3QxM2pqZElFM2d3bE9VMVF6S3NHTWhWVWF6N01oVjc2RzFURnpsS0ZHcVRUVkQwRmJxZ1lhY2Rid2xSUndvdFhKeEduRGNqSWd0emhRcERYbWpxSjdleUhpMzJyWGFNemlndFhQSi1HTFo5TDV0N1NMRHdIeXRNM0tDT2xMeFhYcDE2d0lwWF81NVJxcmY4b3YyVkswX2VJMGswcmVWMA?oc=5","date":"2021-01-13","type":"pipeline","source":"Urology Times","summary":"MD Anderson, UroGen Pharma collaborate on novel immunotherapy for NMIBC - Urology Times","headline":"MD Anderson, UroGen Pharma collaborate on novel immunotherapy for NMIBC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxNTGdxZ3VGSnhIZjZLQ2dLN1hxSTFDZ241MHkzTmRvQWFhbDllcTFGSDA3eTdJRkJpelEwQ2FvTzhhTmRnV0IxV3NNTGJkM0QyOWN1eVN5b2RydFphRUxZRi1GX2dYUDRrYkpLbTc5c0tNZDVpZzdxbEw0QWRSN0ctdGRRVXNhNEtONm5sRUIyNEZ2ZHh5dGRYeWZOelI3Y01fVGZsYTh5YmFIRkk5aFIyajF1cmNTcXZ2NHROVGR6UUxpNXNXai1ndkVvS2RNN2tNRDlsa3VkcW8tczcyamdNclFiVG5NWEN4SHpjMWVaT1NDWm40dWlYeWdTWG50ckxETlE0VUlNOGI2RTBFeG5MekduNFl0UQ?oc=5","date":"2018-08-06","type":"regulatory","source":"PR Newswire","summary":"Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic Malignancies - PR Newswire","headline":"Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic M","sentiment":"neutral"}],"patents":[],"drugCount":71,"phaseCounts":{"marketed":29,"discontinued":8,"phase_2":5,"phase_3":19,"phase_1":10},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}